SCHEMBL11954729

SCHEMBL11954729

O[C@]12CCOC[C@@H]1CCC[C@H]2Nc1ccc(F)cc1

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 11/20 0.70
TRPC5 Q9UL62 2/20 0.49
ESR1 P03372 1/20 0.49
PGR P06401 1/20 0.49
HTR2A P28223 1/20 0.49
SLC6A3 Q01959 1/20 0.49
HSD11B1 P28845 2/20 0.39
POLB P06746 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
EPHX1 P07099 1/20 0.33
HRH2 P25021 1/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
MAPK8 P45983 1/20 0.31
MAPK10 P53779 1/20 0.31
MAPK14 Q16539 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15809945 1.00 TRPA1 (0.70) TRPA1TRPC5ESR1PGRHTR2A
SCHEMBL11966324 1.00 TRPA1 (0.70) TRPA1TRPC5ESR1PGRHTR2A
SCHEMBL11971169 0.87 TRPA1 (0.51) TRPA1TRPC5ESR1PGRHTR2A
SCHEMBL15809994 0.87 TRPA1 (0.51) TRPA1TRPC5ESR1PGRHTR2A
SCHEMBL3214 0.87 TRPA1 (0.51) TRPA1TRPC5ESR1PGRHTR2A
SCHEMBL15809851 0.86 TRPA1 (0.52) TRPA1TRPC5ESR1PGRHTR2A
SCHEMBL2522 0.86 TRPA1 (0.52) TRPA1TRPC5ESR1PGRHTR2A
SCHEMBL12096 0.86 TRPA1 (0.52) TRPA1TRPC5ESR1PGRHTR2A
SCHEMBL3120 0.83 TRPA1 (0.71) TRPA1TRPC5ESR1PGRHTR2A
SCHEMBL11971240 0.83 TRPA1 (0.71) TRPA1TRPC5ESR1PGRHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2485737-B1 NOVEL TRPA1 ANTAGONISTS MERCK SHARP & DOHME (US) 2014-06-25 EP claimed
US-8829196-B2 TRPA1 antagonists MERCK SHARP & DOHME CORP. (US) 2014-09-09 US disclosed
US-8829196-B2 TRPA1 antagonists MERCK SHARP & DOHME CORP. (US) 2014-09-09 US disclosed
EP-2485737-B1 NOVEL TRPA1 ANTAGONISTS MERCK SHARP & DOHME (US) 2014-06-25 EP disclosed
EP-2485737-B1 NOVEL TRPA1 ANTAGONISTS MERCK SHARP & DOHME (US) 2014-06-25 EP disclosed
US-20120196894-A1 NOVEL TRPA1 ANTAGONISTS SCHERING CORPORATION 2012-08-02 US disclosed
US-20120196894-A1 NOVEL TRPA1 ANTAGONISTS SCHERING CORPORATION 2012-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196894-A1 NOVEL TRPA1 ANTAGONISTS TRPA1, TRPV1, TRPV2 TRPA1 1/4885TRPC5 15/4885ESR1 3872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.